C3El.Cg-PklrM1Neu/Ieg

Status

Available to order

EMMA IDEM:01946
Citation informationRRID:IMSR_EM:01946 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC3El.Cg-PklrM1Neu/Ieg
Alternative namePK10681
Strain typeInduced Mutant Strains : Chemically-induced
Allele/Transgene symbolPklrM1Neu
Gene/Transgene symbolPklr

Information from provider

ProviderWalter Pretsch
Provider affiliationInstitute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH)
Genetic informationThe mutation results in pyruvate kinase (Pk-1; pyruvate kinase liver and red blood cell, Pklr gene) hyperactivity. It is suggested that the regulatory locus of Pk-1 is affected by this mutation.
Phenotypic informationThe PK activity alteration was detected in blood and could also be found in the liver but not in muscle, kidney, heart, spleen, lung, or brain. Heterozygous mice have erythrocyte PK activity enhanced up to about 160% and homozygotes up to about 240%, compared to homozygous wild-type mice. The heterozygous and homozygous mutants are viable and fully fertile and do not show symptoms of erythrocytosis. The mutation does not affect the heat stability, the electrophoretic mobility, or the Km (for phosphoenolpyruvate) of the PK protein.
Breeding historyC3H/El (7th generation)
References
  • Linear dose-response relationship of erythrocyte enzyme-activity mutations in offspring of ethylnitrosourea-treated mice.;Charles D J, Pretsch W, ;1987;Mutation research;176;81-91; 3796661
  • The liver/erythrocyte pyruvate kinase gene complex [Pk-1] in the mouse: regulatory gene mutations.;Fitton L A, Davidson M, Moore K J, Charles D J, Pretsch W, Elston R C, Bulfield G, ;1991;Genetical research;58;233-41; 1802805

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

    • Hemolytic anemia due to red cell pyruvate kinase deficiency / Orphanet_766
MGI phenotypes (gene matching)
  • decreased hematocrit / MGI
  • abnormal erythropoiesis / MGI
  • enlarged spleen / MGI
  • anemia / MGI
  • hemolytic anemia / MGI
  • no abnormal phenotype detected / MGI
  • abnormal erythrocyte morphology / MGI
  • increased mean corpuscular volume / MGI
  • reticulocytosis / MGI
  • decreased hemoglobin content / MGI
  • decreased erythrocyte cell number / MGI
  • increased erythroid progenitor cell number / MGI
  • abnormal erythrocyte osmotic lysis / MGI
  • decreased susceptibility to parasitic infection / MGI
  • increased circulating bilirubin level / MGI
  • abnormal enzyme/coenzyme activity / MGI
  • hemosiderosis / MGI
  • abnormal common myeloid progenitor cell morphology / MGI
  • increased nucleated erythrocyte cell number / MGI
  • increased susceptibility to bacterial infection induced morbidity/mortality / MGI
  • increased erythrocyte clearance / MGI
  • decreased susceptibility to parasitic infection induced morbidity/mortality / MGI
  • increased erythroblast number / MGI

Literature references

  • Linear dose-response relationship of erythrocyte enzyme-activity mutations in offspring of ethylnitrosourea-treated mice.;Charles D J, Pretsch W, ;1987;Mutation research;176;81-91; 3796661
  • The liver/erythrocyte pyruvate kinase gene complex [Pk-1] in the mouse: regulatory gene mutations.;Fitton L A, Davidson M, Moore K J, Charles D J, Pretsch W, Elston R C, Bulfield G, ;1991;Genetical research;58;233-41; 1802805

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).